Birger Sørensen

746 total citations
33 papers, 506 citations indexed

About

Birger Sørensen is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Birger Sørensen has authored 33 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Virology, 13 papers in Immunology and 12 papers in Infectious Diseases. Recurrent topics in Birger Sørensen's work include HIV Research and Treatment (16 papers), Immunotherapy and Immune Responses (10 papers) and Bacterial Infections and Vaccines (9 papers). Birger Sørensen is often cited by papers focused on HIV Research and Treatment (16 papers), Immunotherapy and Immune Responses (10 papers) and Bacterial Infections and Vaccines (9 papers). Birger Sørensen collaborates with scholars based in Norway, Sweden and United Kingdom. Birger Sørensen's co-authors include Bjørn‐Erik Kristiansen, Maja A. Sommerfelt, Bjarne Bjorvatn, Ingebjørg Baksaas, Dag Kvale, Anne‐Marte Bakken Kran, Oddvar Spanne, Johan N. Bruun, K Melby and E S Falk and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Clinical Microbiology.

In The Last Decade

Birger Sørensen

32 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birger Sørensen Norway 15 199 174 157 141 138 33 506
Michael Klutch United States 13 209 1.1× 173 1.0× 70 0.4× 65 0.5× 134 1.0× 23 494
V. Mazarin France 11 165 0.8× 87 0.5× 55 0.4× 158 1.1× 120 0.9× 12 441
Fons Bosman Belgium 10 235 1.2× 60 0.3× 119 0.8× 100 0.7× 168 1.2× 16 539
Leonard Both United Kingdom 12 91 0.5× 113 0.6× 120 0.8× 40 0.3× 127 0.9× 14 459
Charlotta Bergquist Sweden 8 201 1.0× 53 0.3× 258 1.6× 87 0.6× 66 0.5× 8 505
Miroslav Novák United States 16 308 1.5× 36 0.2× 318 2.0× 59 0.4× 161 1.2× 31 780
María Villacrés-Eriksson Sweden 13 98 0.5× 83 0.5× 314 2.0× 31 0.2× 127 0.9× 15 456
A Daas Belgium 11 112 0.6× 45 0.3× 68 0.4× 103 0.7× 67 0.5× 53 345
Dihan Zhou China 15 161 0.8× 29 0.2× 210 1.3× 142 1.0× 234 1.7× 27 625
Neelima Sukumar United States 12 321 1.6× 102 0.6× 155 1.0× 217 1.5× 303 2.2× 15 798

Countries citing papers authored by Birger Sørensen

Since Specialization
Citations

This map shows the geographic impact of Birger Sørensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birger Sørensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birger Sørensen more than expected).

Fields of papers citing papers by Birger Sørensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birger Sørensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birger Sørensen. The network helps show where Birger Sørensen may publish in the future.

Co-authorship network of co-authors of Birger Sørensen

This figure shows the co-authorship network connecting the top 25 collaborators of Birger Sørensen. A scholar is included among the top collaborators of Birger Sørensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birger Sørensen. Birger Sørensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rahbar, Afsar, Marcus Carlsson, Tove Hoffman, et al.. (2023). Influenza-A mediated pre-existing immunity levels to SARS-CoV-2 could predict early COVID-19 outbreak dynamics. iScience. 26(12). 108441–108441. 4 indexed citations
2.
Sørensen, Birger, Maja A. Sommerfelt, Peter L. Smith, et al.. (2017). Correlation of Antibody Responses to a Peptide Antigen gp120-C5 501–512 /gp41 732–744 with HIV Disease Progression. AIDS Research and Human Retroviruses. 33(6). 558–566. 3 indexed citations
3.
Meijerhof, Tjarko, Hubert G.M. Niesters, Arnt‐Ove Hovden, et al.. (2017). A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model. Virology. 515. 21–28. 34 indexed citations
4.
Lind, Andreas, Carol Holm‐Hansen, Inger Lise Haugen, et al.. (2014). Intranasal Administration of a Therapeutic HIV Vaccine (Vacc-4x) Induces Dose-Dependent Systemic and Mucosal Immune Responses in a Randomized Controlled Trial. PLoS ONE. 9(11). e112556–e112556. 23 indexed citations
5.
Lind, Andreas, Maja A. Sommerfelt, Jens Holmberg, et al.. (2012). Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years. Scandinavian Journal of Infectious Diseases. 44(8). 566–572. 9 indexed citations
6.
Kran, Anne‐Marte Bakken, Maja A. Sommerfelt, Ingebjørg Baksaas, Birger Sørensen, & Dag Kvale. (2011). Delayed‐type hypersensitivity responses to HIV Gag p24 relate to clinical outcome after peptide‐based therapeutic immunization for chronic HIV infection. Apmis. 120(3). 204–209. 5 indexed citations
7.
Kran, Anne‐Marte Bakken, et al.. (2010). Low frequency of amino acid alterations following therapeutic immunization with HIV-1 Gag p24-like peptides. AIDS. 24(17). 2609–2618. 7 indexed citations
8.
Sommerfelt, Maja A. & Birger Sørensen. (2008). Prospects for HIV-1 therapeutic immunisation and vaccination: the potential contribution of peptide immunogens. Expert Opinion on Biological Therapy. 8(6). 745–757. 7 indexed citations
9.
Kvale, Dag, Anne‐Marte Bakken Kran, Maja A. Sommerfelt, et al.. (2005). Divergent in vitro and in vivo correlates of HIV-specific T-cell responses during onset of HIV viraemia. AIDS. 19(6). 563–567. 14 indexed citations
10.
11.
Kran, Anne‐Marte Bakken, Maja A. Sommerfelt, Birger Sørensen, et al.. (2005). Reduced viral burden amongst high responder patients following HIV-1 p24 peptide-based therapeutic immunization. Vaccine. 23(31). 4011–4015. 26 indexed citations
12.
Kran, Anne‐Marte Bakken, Birger Sørensen, Maja A. Sommerfelt, et al.. (2004). HLA- and dose-dependent immunogenicity of a peptide-based HIV-1 immunotherapy candidate (Vacc-4x). AIDS. 18(14). 1875–1883. 38 indexed citations
13.
Sommerfelt, Maja A., et al.. (2003). A simple semi-rapid HIV-1&2 confirmatory immunoassay using magnetic particles. Journal of Virological Methods. 115(2). 191–198. 11 indexed citations
14.
Albrektsen, Grethe, et al.. (2003). Changes in Immunoglobulin Isotypes and Immunoglobulin G (IgG) Subclasses During Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 34(4). 358–367. 19 indexed citations
15.
Åsjö, Birgitta, et al.. (2002). Phase I Trial of a Therapeutic HIV Type 1 Vaccine, Vacc-4x, in HIV Type 1-Infected Individuals with or without Antiretroviral Therapy. AIDS Research and Human Retroviruses. 18(18). 1357–1365. 33 indexed citations
16.
Falk, E S, Bjarne Bjorvatn, Bjørn‐Erik Kristiansen, et al.. (1986). Some phenotypic and genotypic characteristics of prevailing gonococcal strains in northern Norway.. Sexually Transmitted Infections. 62(1). 9–14. 5 indexed citations
17.
Kristiansen, Bjørn‐Erik, Birger Sørensen, Bjarne Bjorvatn, et al.. (1986). An outbreak of group B meningococcal disease: tracing the causative strain of Neisseria meningitidis by DNA fingerprinting. Journal of Clinical Microbiology. 23(4). 764–767. 48 indexed citations
18.
Danielsson, Dan, et al.. (1985). Genomic fingerprinting in the epidemiology of gonorrhoea. Acta Dermato Venereologica. 65(3). 235–239. 14 indexed citations
19.
Dahl, Tor, Birger Sørensen, Staffan Sundell, et al.. (1985). Solid Addition Complexes of Tetramethylbenzenes with Fluoranil and Hexafluorobenzene. Crystal Structure of the 1:1 Complex between Durene and Fluoranil.. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 39b. 423–428.
20.
Falk, Edvard S., Bjarne Bjorvatn, Dan Danielsson, et al.. (1984). RESTRICTION ENDONUCLEASE FINGERPRINTING OF CHROMOSOMAL DNA OF NEISSERIA GONORRHOEAE. Acta Pathologica Microbiologica Scandinavica Series B Microbiology. 92B(1-6). 271–278. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Klutch Breakdown of academic impact, for papers by V. Mazarin Breakdown of academic impact, for papers by Fons Bosman Breakdown of academic impact, for papers by Leonard Both Breakdown of academic impact, for papers by Charlotta Bergquist Breakdown of academic impact, for papers by Miroslav Novák Breakdown of academic impact, for papers by María Villacrés-Eriksson Breakdown of academic impact, for papers by A Daas Breakdown of academic impact, for papers by Dihan Zhou Breakdown of academic impact, for papers by Neelima Sukumar
Rankless by CCL
2026